Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 98 (3) , 686-698
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Support Program of Jiangsu Province
- National Natural Science Foundation of China
This publication has 65 references indexed in Scilit:
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJournal of Clinical Investigation, 2011
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in miceJournal of Clinical Investigation, 2011
- Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthProceedings of the National Academy of Sciences, 2011
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1Molecular Cell, 2010
- Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidneyAmerican Journal of Physiology-Renal Physiology, 2009
- An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic miceNature Medicine, 2008
- Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-β1Experimental Cell Research, 2007
- mTOR, translational control and human diseaseSeminars in Cell & Developmental Biology, 2005
- EFFECTS OF RAPAMYCIN IN EXPERIMENTAL ORGAN ALLOGRAFTINGTransplantation, 1993